The Motley Fool Highlights Top Pharmaceutical Stocks for 2026 Key Trends and Investment Considerations YRD Q2 2025 Earnings Strong EPS of 409 Reported But Stock Declines 442 Micron Stock Could Surge 85 as Analyst Highlights AI Memory Demand Potential